Where Global Innovation
and Capital Meet

Mars Innovation and Schrödinger open up Bright Angel Therapeutics

Dec 21, 2017 •

The pair will anchor Bright Angel Therapeutics as founding shareholders, providing resources to drive an antifungal enhancement program advancing discoveries made at MIT and University of Toronto.

Bright Angel Therapeutics, a Canada-based fungal inhibitor developer based on Massachusetts Institute of Technology (MIT) and University of Toronto research, was publicly unveiled today to develop drugs that help overcome resistance to existing antifungal medicines.
Multi-university commercialisation firm Mars Innovation and drug discovery company Schrödinger are the company’s founding shareholders, however further details of their agreement were not disclosed.
Founded in 2016, Bright Angel hopes to develop a drug that inhibits the chaperone protein Hsp90, which is thought…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?

LEADERSHIP SOCIETY

Informing, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.

Find out more

University of Notre Dame tries new, supersized approach to creating spinouts

A new $35m fund will be managed by external venture studio High Alpha Innovation and will work with the university on creating new startups.

University of Tokyo investment arm forms deeptech fund

University of Tokyo’s third investment fund reached a first close with capital from Tokyu Land and the Tokyo Metropolitan Government.

New fund to target University of Arkansas startups

Venture firm 46VC’s Dickson & Main Fund I will invest in companies associated with the university or the local Arkansas ecosystem.

Events

GCV Institute: Landing the Value of Corporate Venturing

May 6 -
May 9, 2024
Online

Find out more All events

Events

Webinar: CVCs and the art of the follow-on

May 8, 2024
Online

Find out more All events

Events

GCV Institute: CVC Investment Programs

May 21 -
May 22, 2024
Online

Find out more All events

Events

GCV Symposium 2024

Jun 24 -
Jun 26, 2024
London (UK)

Find out more All events

Events

Corporate Venture in Brasil 2024 – International Delegation to Brazil

Oct 28 -
Oct 30, 2024
São Paulo (Brazil)

Find out more All events

About us

Global University Venturing (GUV) is where tech transfer, academic and investment experts meet to explore the latest ideas and technologies driving innovation forward. We drive the discussions and share best practices that are critical to the success of spinouts, scaleouts and innovation programmes. Our aim is to help improve the processes of bringing innovations from academia to global markets and facilitate their integration into the broader business ecosystem.